Fibromyalgia Trial, Recruiting NCT07356206 Sponsor: University of Minho Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07356206
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been officially diagnosed with fibromyalgia
  • You are currently being seen at ULS Alto Ave by one of the following specialist teams: the Multidisciplinary Pain Unit, Internal Medicine (for autoimmune diseases), Physical and Rehabilitation Medicine, or Neurology
  • You are able to read, write, and understand Portuguese, and can understand what the study involves
  • You are willing and able to attend all 10 sessions of the program and all scheduled check-in appointments
  • You are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • You have an allergy to dogs or a strong fear of dogs
  • You have a history of aggressive behaviour toward animals
  • You have a history of cancer
  • You have another ongoing condition affecting your whole body or joints that could make it difficult to accurately assess your pain or physical function (confirm with trial site)
  • You have an unstable mental health condition or significant memory or thinking difficulties that could affect your ability to understand or follow the study program (confirm with trial site)
  • You do not wish to take part, or you decide to withdraw your consent at any stage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Armando Almeida, Associate Professor, School of Medicine, University of Minho

Phone: +351 936615717

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Minho
Registry
ClinicalTrials.gov
Start date
22 January 2026
Est. completion
30 June 2028

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Pain intensity (maximum and average) and pain interference; Fibromyalgia impact and functional status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov